BioLoomics
Boulder
About BioLoomics
BioLoomics is a biotechnology company that uses directed evolution to develop antibodies with programmable spatial fate in target cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.1M
- Funding stage: Seed
- Last round: Seed (Sep 2023)
- Website: bioloomics.com
- Phone: 303-955-7982
Industries & Categories
Biotechnology, Health Care, Sensor
Social Profiles
Canonical: https://fsome.com/organization/bioloomics-38334 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.